Ninth Annual Recent Advances and New Directions in Cancer Therapy Conference, in Cooperation With th

Venue: The Westin Pasadena

Location: Pasadena, CA., United States

Event Date/Time: May 14, 2010 End Date/Time: May 16, 2010
Report as Spam


This activity is presented by Physicians’ Education Resource in conjunction with the California Cancer Consortium (City of Hope Comprehensive Cancer Center, Hershey Cancer Institute, University of California, Davis Cancer Center, University of Pittsburgh Medical Center, and USC/Norris Comprehensive Cancer Center).

The Ninth Annual Recent Advances and New Directions in Cancer Therapy Conference is designed to provide participants with updates on cutting-edge clinical trial design and therapeutic strategies for a variety of tumor types, including lung, breast, gastrointestinal, hematologic, gynecologic, and genitourinary cancers. Moreover, the conference will enhance awareness of novel agents in development in an effort to increase the quality of clinical trials and the number of patients enrolled in those trials. The format will include didactic presentations to create awareness and increase knowledge. In addition, there will be extensive interaction through the use of roundtable discussions and audience polling. Question-and-answer sessions will give participants the opportunity to reflect on their practice patterns and discuss barriers and strategies for implementation with their peers.


191 North Los Robles Ave.
United States

Additional Information

At the conclusion of this conference, you should be able to: Assess the prognostic and predictive value of molecular biomarkers for patients with cancer Discuss the role of patient/tumor characteristics in designing personalized therapy for patients with cancer Select novel targeted therapies that optimize efficacy and minimize side effects based on tumor characteristics Evaluate the efficacy and safety of novel agents in the treatment of patients with cancer based on the results of recent clinical trials Evaluate clinical trial and translational methodologies for proper use in the clinical investigation decision-making process Describe the necessary elements for an effective clinical trial in patients with cancer